While the planned formal analysis for pCR did not reach statistical significance, the experimental arm showed numerically higher pCR rates with durvalumab versus without (33.8% vs 25.8%) [ 38 ].
1
—
—
While the planned formal analysis for pCR did not reach statistical significance, the experimental arm showed numerically higher pCR rates with durvalumab versus without (33.8% vs 25.8%) [ 38 ].